- Medicaid work rules: What’s in, what’s out and where hospitals stand
- Med-Metrix to acquire Vitalware from Health Catalyst
- 850 Virtua nurses issue strike notice
- What leaders need to know about the breakthrough pancreatic cancer pill
- SSM Health receives $10M from MLS team owner
- Hospital CEO: BCBS Alabama must pay us by June 25, or closure begins
- Deaconess hospital taps new chief administrative officer
- 61% of high-risk Minnesota Medicaid providers face disenrollment amid $2B threat
- 3 dental technologies earning FDA clearance
- Novant Health pilots AI-powered virtual assistant
- Fraud crackdown heats up: 9 physicians in 60 days
- Optum to close another Indiana physician practice
- Closures, bankruptcies and consent orders: 5 ASC controversies from the last year
- 3 years and up to 15,000 fake nursing degrees later, Operation Nightingale reaches trial
- The No Surprises Act’s game of ‘hot potato’
- New Maryland law expands assignment of benefit protections for dentists, patients
- Insurers overturn 80% of denied IBD therapy claims on appeal — but only 4% are ever challenged
- Rhode Island House passes bill expanding reimbursement options for hygienists: 5 notes
- Dental assistants’ pay jumped the most in these 10 states
- 4 charged in $30M behavioral health fraud case
- Medicaid termination notices disrupt South Florida behavioral healthcare
- Cooper University Health Care plans $300M ASC, outpatient campus
- “Harmonization: We’ll Have Lots to Talk About”
- HUD overhauls $4B homelessness program
- Heartland Dental added 8 practices in May
- What the USAP-FTC settlement means for ASC anesthesia contracting
- 15 spine surgeons to know
- Ascension inks $3.9B AmSurg deal, adds 300 ASCs after FTC requires 7 divestitures
- PDS Health marks $1M in tuition assistance for dental assisting students
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- 5 highest-paying cities for dentists in 2026
- Veteran ASC recruiter merges ASC, hospital nursing leadership practices
- ‘The need has not magically decreased’: John Muir temporarily closes 21 psych beds amid California’s staffing order
- Poll Finds Broad Support For Stricter Regulations On Ultra-Processed Foods
- It's unanimous: SCOTUS agrees with Hikma in 'skinny label' case vs. Amarin
- DSOs, dental schools and companies secure $270M in funding boons
- Remarks at the Investor Advisory Committee Meeting
- Nearly 1 in 5 Young People Turn to AI Chatbots for Mental Health Advice
- Georgetown study: 2M children have dropped out of Medicaid, CHIP since January 2025
- ScionHealth sends 8 community hospitals to Lifepoint Health
- ADC Therapeutics' shares plummet after patient deaths in trial of Zynlonta
- As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
- Older LGBTQ+ Adults Fear Less Support As They Age, Poll Shows
- Night Owls Are More Prone To Anxiety, Loneliness
- Home-Delivered Medical Meals Reduce ER Visits, Save Money
- Axsome fends off generic competition to narcolepsy med Sunosi until 2040
- Menopause Hormone Therapy Use Drops Sharply Across United States
- Michigan Found A Way To Reduce School Vaccine Waivers — Until It Backfired
- Listen to the Latest ‘KFF Health News Minute’
- RFK Jr. Seeks To Peek at Americans’ Medical Records for Clues on Autism and Vaccines
- Louisiana’s Reporting Law Chills Immigrant Medicaid Applications
- Thyme Care expands cancer survivorship program to provide longitudinal support
- Medline earns FDA warning letter ire for repeated toxic bacteria problems
- House committee advances federal dental workforce bill
- Pearl, Seattle Study Club partner on dental AI education
- Michigan psychiatric hospitals cut patient injuries 58%
- 28 behavioral health executive moves to know
- Carilion behavioral health role cuts staff injuries 70%-90%
- Trump’s Medicaid Work Rules Force States To Scrap Plans and Rework Systems
- UnitedHealthcare used false behavioral health diagnoses to defraud Massachusetts Medicaid, lawsuit alleges
- US overdose deaths drop 24.4%, largest decline on record: 6 things to know
- Adult drug use disorder rates by state
- Commonwealth Fund: 21% of adults experienced a coverage denial in the past year
- Millions on Medicaid May Soon Have To Prove They’re Working To Keep Coverage
- Anomaly Insights launches AI solution for managed care executives
- Lilly, Boehringer to slash at least $1B each from planned investments in Germany
- Presbyterian Healthcare Services to discontinue MA plans in 2027, cut 150 jobs
- Just 90 Minutes Of Strength Training A Week Linked To Longer Life
- AHA lays out blueprint to improve affordability, care access and quality
- Amid Miplyffa launch, Zevra CEO aims to foster EU-style Niemann-Pick market in US
- Chemo-Free Drug, Tecvayli, Shows Major Survival, Remission Gains In Relapsed Multiple Myeloma
- Urine Test Can Detect Autism, Study Says
- High-Puff Vapes Become More Toxic Over Time, Study Says
- With Cencora pact, Gilead looks to grow CAR-T treatment center network
- The watchdog overseeing the integrity of HHS programs
- Coffee, racetracks, beaches and more coffee—inside the ASCO 2026 exhibit floor
- GLP-1 Drugs Like Ozempic May Lower Breast Cancer Risk By About 30%
- Telehealth Booms As Demand For GLP-1s Surges and Questions Mount About Safety, Oversight
- At a Tennessee Hospital, a Nurse Stole Fentanyl and AI Missed It, State Records Say
- Michigan Found a Way To Reduce School Vaccine Waivers. Until It Backfired.
- A patient-first shift in disease language and communication
- FDA issues untitled letter after finding ‘eye-catching graphics’ in promotional emails
- Neurotech launches new YouTube channel to spotlight patients’ stories for rare eye disorder
- As Akeso takes center stage at ASCO, China biotech industry cements its coming of age
- Base Case: Remarks at the IC3 Blockchain Camp
- Microsoft, Mayo Clinic plan to build frontier AI model for healthcare
- OIG: Feds may have overpaid MA plans by millions due to unsupported stroke diagnoses
- Department of Labor's proposed foreign worker wage increases are more tough news for healthcare staffing
- Trump Signs Order Calling For Fewer Childhood Vaccines
- Industry groups say final Medicaid work requirements rule imposes onerous documentation burden
- Ascension closes its $3.9B AmSurg purchase following FTC's all-clear
- Simple Blood Test May Help Detect And Stage Alzheimer's Disease
- Festering Infections to Untreated Cancer: ICE Detainees Describe Medical Neglect Across US
- A look at wearable adoption trends and who's using 'smart' devices: Rock Health
- Eli Lilly's ultimatum to hospitals: Send 340B claims data by June 8 or lose discounts
- Eli Lilly's ultimatum to hospitals: Send 340B claims data by June 8 or lose discounts
- Marilyn Monroe and Amy Schumer profiled in endometriosis awareness push
- Merck shrinks headcount by 88 in New Jersey as $3B cost-cutting scheme advances
- Joint Commission launches voluntary AI certification program for healthcare organizations
- Gilead's Livdelzi scores in rare liver disease trial, portending use in broader patient population
- Smartphone App Helps Those With Advanced Cancer Maintain Quality Of Life
- Asthma Drug, Tezspire, Cuts Need For Steroid Pills While Keeping Attacks In Check
- Childhood Flu Shots Prevent Millions of Cases, Study Finds
- Sanofi taps Snowflake for AI field agent help
- Merck weighs use of COVID antiviral Lagevrio as Ebola outbreak worsens
- ADHD drug delivery specialist Cingulate hit with manufacturing-related FDA rejection
- Amid Ebola, Hantavirus Outbreaks, Democrats Decry Trump's Health Cuts
- TikTok Videos Fuel Illicit Vaping Culture Among Underage Youth
- Focused on Work, Needed at Home: A Federal Caregiving Policy Might Help
- Eisai whips up Alzheimer’s dietary guidance to expand nutrition program beyond cancer
- AI-powered medical imaging startup Subtle Medical picks up $33M and taps new CEO
- Northwell's firearm injury risk screener now widely available within Epic
- Commission Statement on the Passing of Former General Counsel David Becker
- CMS outlines national framework to support rollout of Medicaid work requirements
- Your Surprise Medical Bill May Be Gone — But Your Premiums Could Still Spike
- Athenahealth rolls out over 80 new, expanded AI RCM features in ‘roadmap’ on athenaOne platform
- Contraline and its male birth control candidate rally $92.5M amid push into 'massive white space' of men's health
- Short-Term Fasting Could Boost Chemo Response in Ovarian Cancer, Study Suggests
- Wolters Kluwer Health survey examines AI use and concerns among clinicians, patients in 2026
- Workout Habits May Protect Against Inherited Heart Problems
- Childhood Lying Is Normal and Rarely Signals Behavioral Concerns, Study Says
- Perfectionism Among College Students Reaches Record High, Fueling Anxiety
- After Her Bout of Amnesia, A $59,000 Billing Dispute Wouldn't Go Away
- Weed Linked To Higher Testosterone Levels In Young Men
- Amid Ebola, Hantavirus Outbreaks, Democrats Decry Trump’s Health Cuts
- Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight
- Rising Stars: WPP’s Meghan O’Hora on the ‘complex puzzle’ of oncology drug marketing
- Contraception For Teens: Let's Talk About It
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- CAT on a Hot Tin Roof
- Remarks at the Stanford Rock Center for Corporate Governance
- Statement on Novel Exchange-Traded Funds (ETFs)
- ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer
- Statement on Proposing Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
Michigan healthcare freedom community forum
The Food and Drug Administration wants to regulate all Laboratory Developed [Medical] Tests (LDTs), also known as In Vitro Diagnostic (IVD) products. Their rule, Docket No. FDA-2023-N-2177, was published in the Federal Register on October 3, 2023. Comment period has since closed, but the rule's future is in doubt:
https://www.fda.gov/media/172557/download?attachment
https://reason.com/2024/03/28/fda-to-test-more-tests/
FDA Aims To Stifle Medical Innovation Again
After botching COVID test approvals, the Food and Drug Administration wants power over thousands of other tests.
By Ronald Bailey | April 2024The Food and Drug Administration (FDA) that massively screwed up COVID-19 testing now wants to apply its vast bureaucratic acumen to all other laboratory developed tests (LDTs). By insisting on its recondite approval procedures, the FDA at the beginning of the pandemic stymied the rollout of COVID-19 tests developed by numerous academic and private laboratories. In contrast, public health authorities in South Korea greenlighted an effective COVID-19 test just one week (and many more in the weeks following) after asking representatives from 20 private medical companies to produce such tests.
LDTs are diagnostic in vitro tests for clinical use that are designed, manufactured, and performed by individual laboratories. They can diagnose illnesses and guide treatments by detecting relevant biomarkers in saliva, blood, or tissues; the tests can identify small molecules, proteins, RNA, DNA, cells, and pathogens. For example, some assess the risks of developing Alzheimer's disease or guide the treatment of breast cancer.
The FDA now wants to regulate these tests as medical devices that must undergo premarket agency vetting before clinicians and patients are allowed to use them. The FDA estimates that between 600 and 2,400 laboratories currently offer as many as 40,000 to 160,000 tests. Overall, some 3.3 billion in vitro tests are administered to patients annually.
Out of billions of tests given, how often do laboratory developed tests appear to cause harm? In its submissions, the FDA justifies this burdensome oversight by citing problematic medical device reports and unconfirmed "allegations" for a grand total of nine and four different tests respectively between 2009 and 2023. The remaining examples cited by the FDA are tests that had actually been submitted to the agency for analysis and were subsequently rejected or revised as recommended.
A 2023 study in the American Journal of Clinical Pathology analyzed how frequently these tests were deployed in the University of Utah health system. The researchers reported that out of the more than 3 million lab tests ordered in 2021, 94 percent of them had already been approved by the FDA. Only 4 percent of the lab tests were LDTs. They believe their figures are similar across the U.S. health care landscape.
The FDA has received strong and widespread pushback from laboratories and clinicians. In a letter to the agency, American Hospital Association Executive Vice President Stacey Hughes wrote of the proposed regulations that "the unfortunate outcome likely would be the decline in the rate of clinical innovation, which would negatively impact the U.S.' ability to keep our health care system at the forefront of discovery, provide quality care to patients, and respond quickly to emerging public health risks."
The Biden administration is aiming to have the regulations finalized in April. However, MedTech Dive reports, analysts at the investment bank TD Cowen suggested that it remains "unclear if and when FDA will finalize the rule as it has faced considerable opposition and would likely be challenged in court."
Nothing succeeds in the Federal Government like repeated failure. 😡
Seriously, this is a terrible idea!
Creeping regulation limits our access to care. What's difficult about this??
FDA brings lab tests under federal oversight in bid to improve accuracy and safety
WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The agency cannot stand by while Americans continue to rely on results from these tests without assurance that they work,” FDA Commissioner Robert Califf told reporters on a conference call.
Califf said inaccurate tests can lead to unnecessary treatment or delays in getting proper care.
But in a significant move, the FDA decided that the tens of thousands of tests currently on the market will not have to undergo federal review. The agency said it will essentially grandfather those tests into approval to address concerns that the new rule “could lead to the widespread loss of access to beneficial” tests.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
Sponsors
J & DE Family Charitable Fund
Friends
of MHF
Kelly Grotendiek
Philip Harbach
Dale Johnson
Drs. Jeffrey and Joni Jones
Vickie Kahle
Tammy Kipen
Marlin & Kathy Klumpp
Melanie Kurdys
Ruth Nobel
Patrick Peterson
Stephanie Poortenga
Jeanne Smit
Ben and Hope Staal
John Tuinstra
Jacki VanHuis
Sandy Walker
Sign Up for MHF Insights to keep up on the latest in Michigan Health Policy
